Remove Cholesterol Remove Lipid disorders Remove Outcomes
article thumbnail

Cholesterol’s Star Role in Dementia Prevention: New Insights from the 2024 Lancet Dementia Report 

Cardiometabolic Health Congress

Newly included risk factors— untreated vision loss and high LDL cholesterol —underscore the critical role of these elements in maintaining cognitive health. The Cholesterol Connection Cholesterol’s recognition as a risk factor for dementia marks a pivotal advancement in understanding, preventing, and delaying cognitive decline.

article thumbnail

Harnessing Telehealth and Home Blood Pressure Monitoring to Improve Hypertension Care

Cardiometabolic Health Congress

For instance, while visual signs of high cholesterol can sometimes be detected through a camera, more acute cases may still necessitate an in-person visit. Whether it’s providing tech support, advocating for EHR integration, or offering video visits, we can leverage these advancements to improve patient outcomes.

article thumbnail

FDA Approves Wegovy for Cardiovascular Risk Reduction in Adults with Known Heart Disease and Overweight or Obesity

DAIC

The FDA decision is based on the results of the landmark SELECT phase 3 cardiovascular outcomes trial that examined the effect of adding Wegovy 2.4 1,2 The primary composite outcome occurred in 6.5% 1,2 The primary composite outcome occurred in 6.5% 2 Wegovy 2.4 of patients treated with Wegovy and 8.0% with placebo.

Obesity 111